Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

The DnaJ-DnaK-GrpE Complex as a Selective Drug Target in Mycobacterium Tuberculosis

The aim of the research is to identify selective modulators of the TB bacteria, Mycobacterium tuberculosis (Mtb), to support development of newer, more effective therapies.

More information about Grand Challenges Africa: Drug Discovery